An open-label, prospective, observational study of the incidence of coronary artery disease in Patients with HIV infection receiving highly active antiretroviral therapyBARBARO, Giuseppe; DI LORENZO, Gabriella; CIRELLI, Augusto et al.Clinical therapeutics. 2003, Vol 25, Num 9, pp 2405-2418, issn 0149-2918, 14 p.Article

Time to discontinuation of the first highly active antiretroviral therapy regimen : a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimensDORRUCCI, Maria; PEZZOTTI, Patrizio; GRISORIO, Benvenuto et al.AIDS (London). 2001, Vol 15, Num 13, pp 1733-1736, issn 0269-9370Article

The Pavia consensus statementVOLBERDING, Paul A; MURPHY, Robert L; GALLI, Massimo et al.AIDS (Supplement). 2003, Vol 17, pp S170-S179, issn 1350-2840, SUP1Article

Lopinavir/ritonavir or efavirenz plus two nucleoside analogues as first-line antiretroviral therapy : a non-randomized comparisonDE LUCA, Andrea; COZZI-LEPRI, Alessandro; CIARDI, Maria et al.Antiviral therapy (London). 2006, Vol 11, Num 5, pp 609-618, issn 1359-6535, 10 p.Article

Rapid progression of carotid lesions in HAART-treated HIV-1 patientsMAGGI, Paolo; PERILLI, Francesco; CHIRIANNI, Antonio et al.Atherosclerosis. 2007, Vol 192, Num 2, pp 407-412, issn 0021-9150, 6 p.Article